Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06577493 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Phenazopyridine for Pain Following Urodynamics
A Phase 4 study of Pain After Urodynamic Testing, sponsored by University of South Florida.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT06577493: Recruiting Phase 4 study of Pain After Urodynamic Testing, sponsored by University of South Florida.
NCT06577493 is a Phase 4 study of Pain After Urodynamic Testing that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 66 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06577493, a Phase 4 study of Pain After Urodynamic Testing, is actively recruiting participants, sponsored by University of South Florida.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
Primary Outcome
Scores are measured on a 100mm VAS. The VAS ranges from 0 to 100 with 0 indicating no pain and higher scores indicating greater pain.
Conditions Studied
Interventions
- DRUG Phenazopyridine Hydrochloride 99.5 MG
Study Locations (1)
Florida
- University of South Florida South Tampa Center - Tampa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2024-12-17 |
| Est. Completion | 2025-07-01 |
| Phase | Phase 4 |
What NCT06577493 shows while recruiting
NCT06577493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Pain After Urodynamic Testing appearing as the primary indexed condition, and to 1 intervention - of which Phenazopyridine Hydrochloride 99.5 MG is the first listed.
NCT06577493 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06577493 about?
NCT06577493 is a clinical study titled "Effectiveness of Phenazopyridine for Pain Following Urodynamics". The purpose of the study is to determine if taking phenazopyridine (AZO) at the time of urodynamic study testing will decrease pain experienced by patients after undergoing urodynamic testing.
What is the current status of trial NCT06577493?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2024-12-17. Estimated completion is 2025-07-01.
What conditions does trial NCT06577493 study?
This clinical trial studies the following conditions: Pain After Urodynamic Testing.
What interventions are being tested in trial NCT06577493?
The interventions under investigation include: Phenazopyridine Hydrochloride 99.5 MG (DRUG).
Who is sponsoring clinical trial NCT06577493?
This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06577493 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06577493's enrollment target sits among peer trials
66 1083rd of 2000 higher than 911 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI